Kidney-type glutaminase is a biomarker for the diagnosis and prognosis of hepatocellular carcinoma: a prospective study

PURPOSE: The pathological diagnosis and prognosis prediction of hepatocellular carcinoma (HCC) is challenging due to the lack of specific biomarkers. This study aimed to validate the diagnostic and prognostic efficiency of Kidney-type glutaminase (GLS1) for HCC in prospective cohorts with a large sa...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Laizhu, Su, Ke, Liu, Qi, Li, Binghua, Wang, Ye, Cheng, Chunxiao, Li, Yunzheng, Xu, Chun, Chen, Jun, Wu, Hongyan, Zhu, Mengxia, Mai, Xiaoli, Cao, Yajuan, Peng, Jin, Yue, Yang, Ding, Yitao, Yu, Decai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10633901/
https://www.ncbi.nlm.nih.gov/pubmed/37946141
http://dx.doi.org/10.1186/s12885-023-11601-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10633901/
https://www.ncbi.nlm.nih.gov/pubmed/37946141
http://dx.doi.org/10.1186/s12885-023-11601-y

Ejemplares similares